Grace Therapeutics, Inc. (GRCE)
NASDAQ
$2.43-1.62%
As of Jul 20, 2026
Price history
Key statistics
- Market cap
- —
- P/E ratio
- —
- EPS
- —
- Volume
- 104,804
- 52-week high
- —
- 52-week low
- —
- Open
- $2.44
- Day high
- $2.47
- Day low
- $2.40
Financial highlights
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| 2026 | — | -$7.79M | -$0.47 |
| 2025 | — | -$9.57M | -$0.79 |
| 2024 | — | -$12.85M | -$1.35 |
| 2023 | — | -$42.43M | -$5.71 |
| 2022 | $100M | -$9.82M | -$0.27 |
About Grace Therapeutics, Inc.
A company overview for Grace Therapeutics, Inc. is coming soon.
Similar stocks
Related stocks will appear here soon.
Frequently asked questions
- What is Grace Therapeutics, Inc.'s stock price today?
- GRCE is trading at $2.43 as of Jul 20, 2026.
- Does Grace Therapeutics, Inc. pay a dividend?
- Grace Therapeutics, Inc. did not pay a dividend in its most recent reported fiscal year.